Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling S Weissmueller, E Manchado, M Saborowski, JP Morris, E Wagenblast, ... Cell 157 (2), 382-394, 2014 | 526 | 2014 |
Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs CR Hale, S Majumdar, J Elmore, N Pfister, M Compton, S Olson, ... Molecular cell 45 (3), 292-302, 2012 | 504 | 2012 |
Binding and cleavage of CRISPR RNA by Cas6 J Carte, NT Pfister, MM Compton, RM Terns, MP Terns Rna 16 (11), 2181-2188, 2010 | 195 | 2010 |
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells NT Pfister, V Fomin, K Regunath, JY Zhou, W Zhou, L Silwal-Pandit, ... Genes & Development 29 (12), 2015 | 152 | 2015 |
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53 NT Pfister, C Prives Cold Spring Harbor Perspectives in Medicine, 2017 | 138 | 2017 |
Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells KE Yoh, K Regunath, A Guzman, SM Lee, NT Pfister, O Akanni, ... Proceedings of the National Academy of Sciences 113 (41), E6107-E6116, 2016 | 71 | 2016 |
Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus S Majumdar, P Zhao, NT Pfister, M Compton, S Olson, CV Glover, L Wells, ... RNA, 1-12, 2015 | 55 | 2015 |
Survival outcomes by high‐risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: a propensity‐scored analysis of the National Cancer Data Base S Tian, JM Switchenko, J Jhaveri, RJ Cassidy, MJ Ferris, RH Press, ... Cancer 125 (16), 2782-2793, 2019 | 47 | 2019 |
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair AE Koyen, MZ Madden, D Park, EV Minten, P Kapoor-Vazirani, E Werner, ... Oncogene 39 (25), 4798-4813, 2020 | 39 | 2020 |
Dosimetric factors related to radiation necrosis after 5-fraction radiosurgery for patients with resected brain metastases DG Tanenbaum, ZS Buchwald, J Jhaveri, E Schreibmann, JM Switchenko, ... Practical radiation oncology 10 (1), 36-43, 2020 | 14 | 2020 |
p53, DNA damage, and NAD+ homeostasis. NT Pfister, KE Yoh, C Prives Cell Cycle 13 (11), 2014 | 10 | 2014 |
The influence of histologic grade on outcomes of elderly women with early stage breast cancer treated with breast conserving surgery with or without radiotherapy CE Escott, D Zaenger, JM Switchencko, JY Lin, M Abugideiri, CA Arciero, ... Clinical breast cancer 20 (6), e701-e710, 2020 | 9 | 2020 |
Survival outcomes by HPV status in non-oropharyngeal head and neck cancers: A propensity score matched analysis of population level data. S Tian, JM Switchenko, J Jhaveri, RJ Cassidy, MJ Ferris, RH Press, ... Journal of Clinical Oncology 36 (15_suppl), 6005-6005, 2018 | 8 | 2018 |
More effective systemic therapies are needed for chondrosarcoma: A National Cancer Data Base (NCDB) analysis. KM Xu, JM Switchenko, S Tian, CE Escott, NT Pfister, TW Gillespie, ... Journal of Clinical Oncology 36 (15_suppl), e23508-e23508, 2018 | 4 | 2018 |
Chromatin dysregulation by mutant p53 NT Pfister, C Prives Oncotarget 7922 (PMID 27127877), 2016 | 4 | 2016 |
Radiotherapy for Right-Sided Breast Cancer in a Patient with Pectus Excavatum: A Comparison of Treatment Techniques S Perni, SK Kim, C Chin, NT Pfister, A Tiwari, DP Horowitz Practical Radiation Oncology, Reference: PRRO 620, 2016 | 2 | 2016 |
Rapid Comparative Planning to Predict Oropharyngeal Toxicity Reduction for Proton Therapy vs. VMAT MW McDonald, WA Stokes, S Tian, VR Dhere, KM Xu, NT Pfister, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), e396-e397, 2021 | 1 | 2021 |
Radiomic analysis of radiation induced fibrosis following stereotactic body radiation therapy C Escott, NA Madden, E Schreibmann, S Tian, RJ Cassidy, AI Sutter, ... International Journal of Radiation Oncology, Biology, Physics 105 (1), E505-E506, 2019 | 1 | 2019 |
Survival outcomes by high-risk HPV status in non-oropharynx head and neck squamous cell carcinomas: a propensity-scored analysis of the National Cancer Data Base DRS Tian, JM Switchenko, DRJ Jhaveri, DRRJ Cassidy, MJ Ferris, ... Cancer 125 (16), 2782, 2019 | 1 | 2019 |
Size of Hepatic Metastases on PET/CT versus Pathologic Specimen: Implications for Radiation Treatment Planning DG Tanenbaum, S Goyal, C Zhang, NT Pfister, NA Madden, SK Maithel, ... International Journal of Radiation Oncology, Biology, Physics 102 (3), e63-e64, 2018 | 1 | 2018 |